---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-221544"
form_type: "8-K"
ticker: "CPRX"
cik: "0001369568"
company_name: "CATALYST PHARMACEUTICALS, INC."
filed_at: "2023-08-25T23:59:59+00:00"
generated_at: "2026-06-11T03:21:53.248521+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Catalyst Pharma elects seven directors at annual meeting; Philip Coelho retires from board

## Summary
- Patrick J. McEnany, Richard J. Daly, Donald A. Denkhaus, Molly Harper, Charles B. O’Keeffe, Tamar Thompson, and David S. Tierney elected to board for 2024 term.
- Philip H. Coelho, board member since 2002, did not stand for re-election; retirement not due to any disagreement.
- Shareholders approved amendment to 2018 Stock Incentive Plan with 73.2M for, 2.7M against.
- Advisory vote on named executive officer compensation passed with 72.6M for, 2.9M against.
- Ratification of Grant Thornton as auditor for FY2023 approved with 87.6M for, 0.3M against.

## SEC filing metadata
- accession: 0001193125-23-221544
- form_type: 8-K
- ticker: CPRX
- cik: 0001369568
- company_name: CATALYST PHARMACEUTICALS, INC.
- filed_at: 2023-08-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369568/000119312523221544/0001193125-23-221544-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369568/000119312523221544/d540429d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-221544
- JSON: https://secwatch.observer/filing/0001193125-23-221544.json
- Plain text: https://secwatch.observer/filing/0001193125-23-221544.txt

## Key facts
- Executive change
  Philip H. Coelho retired as Director at CATALYST PHARMACEUTICALS, INC..
  - Action: retired
  - Role: Director
  source text: Philip H. Coelho, an independent member of the Board, did not stand for re-election at the Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1369568/000119312523221544/0001193125-23-221544-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.